Fennec Pharmaceuticals Inc (FENC) — Capital Reinvestment Ratio

Latest as of March 2026: 0.00x

Fennec Pharmaceuticals Inc (FENC) has a Capital Reinvestment Ratio of 0.00x as of March 2026, meaning it reinvests 0% of its operating cash flow ($2.38 Million) in capital expenditures ($1.00). Check tangible net worth ratio of Fennec Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$2.38 Million

USD

Capital Expenditures

$1.00

USD

Data as of

Mar 2026

Most recent filing

Annual Capital Reinvestment Ratio for Fennec Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Fennec Pharmaceuticals Inc from None to None. See FENC free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow